Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profilesBetty M. Tijms, Pieter Jelle Visser, Eleonora M. Vromen et al.|Nature Aging|2024Cited by 195
The sequence of structural, functional and cognitive changes in multiple sclerosisIris Dekker, Viktor Wottschel, Iman Brouwer et al.|NeuroImage Clinical|2020Cited by 39